While Relmada Therapeutics Inc has overperformed by 3.21%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RLMD rose by 765.38%, with highs and lows ranging from $5.12 to $0.24, whereas the simple moving average jumped by 234.59% in the last 200 days.
On November 19, 2025, Mizuho Upgraded Relmada Therapeutics Inc (NASDAQ: RLMD) to Outperform. A report published by Mizuho on December 05, 2024, Downgraded its rating to ‘Neutral’ for RLMD. Jefferies also Upgraded RLMD shares as ‘Buy’, setting a target price of $13 on the company’s shares in a report dated September 17, 2024. Goldman June 05, 2024d the rating to Sell on June 05, 2024, and set its price target from $3 to $2. Truist October 14, 2022d its ‘Buy’ rating to ‘Hold’ for RLMD, as published in its report on October 14, 2022. Goldman also rated the stock as ‘Neutral’.
Analysis of Relmada Therapeutics Inc (RLMD)
To gain a thorough understanding of Relmada Therapeutics Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -196.79% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.86, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and RLMD is recording an average volume of 1.06M. On a monthly basis, the volatility of the stock is set at 12.27%, whereas on a weekly basis, it is put at 11.67%, with a gain of 8.70% over the past seven days. Furthermore, long-term investors anticipate a median target price of $10.00, showing growth from the present price of $4.5, which can serve as yet another indication of whether RLMD is worth investing in or should be passed over.
How Do You Analyze Relmada Therapeutics Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 13.85%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 14.57% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
